Content of Guidelines·Consensus·Interpretation in our journal

Published in last 1 year |  In last 2 years |  In last 3 years |  All Please wait a minute... For Selected: Download Citations EndNote Ris BibTeX Toggle Thumbnails Select Chinese Expert Consensus on Clinical Management of the Psychosomatic Symptoms in Patients with Cancer YIN Yingying, ZHAO Kuan, WANG Cailian, TANG Lichen, HE Hongbo, LIU Xiangxin, PAN Yu, YANG Hailong, YANG Yang, ZHOU Bo, XIE Ke, LIN Zheng, YU Linzhen, LUO Yanli, LU Zheng, WANG Xiaoping, REN Tao, ZOU Shaohong, WEI Jing, FENG Wei, YUAN Yonggui Chinese General Practice    2025, 28 (15): 1809-1822.   DOI: 10.12114/j.issn.1007-9572.2024.0575 Abstract （890）   HTML （51）    PDF（pc） （1419KB）（366）       Knowledge map    Save Cancer patients are often accompanied by serious psychosomatic symptoms such as depression, anxiety, insomnia and pain, which seriously affect the quality of life and prognosis of patients. However, these symptoms are often under-appreciated and poorly treated. At present, the domestic consensus on the management of cancer lacks the content of psychosomatic symptoms. Therefore, this consensus systematically describes the clinical management methods of psychosomatic symptoms related to cancer patients, combining relevant literature and integrating practical management tools. It comprehensively answers the important questions of physician-patient communication, diagnosis and evaluation, psychological intervention, drug treatment, and how to establish the physician-nurse-patient-family alliance of cancer-related psychosomatic symptoms. Aim at raising awareness of cancer-related psychosomatic symptoms among non-psychiatrists, and selecting effective communication, treatment and management of psychosomatic symptoms with the help of psycho-psychological and other multidisciplinary teams. Table and Figures | Reference | Related Articles | Metrics Select Interpretation of Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement 2022 ZHANG Qi, HE Shen, LI Hua Chinese General Practice    2025, 28 (15): 1823-1830.   DOI: 10.12114/j.issn.1007-9572.2024.0569 Abstract （452）   HTML （14）    PDF（pc） （1295KB）（165）       Knowledge map    Save In 2022, the United States Preventive Services Task Force (USPSTF) published a recommendation statement on Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement in JAMA with an updated evidence report and results of a systematic evaluation (USPSTF statement). The statement suggested screening for major depressive disorder in adolescents aged 12 to 18 years. However, the evidence regarding the risks and benefits of suicide screening for children and adolescents is insufficient, making it challenging to determine its overall impact. This article interprets the content of the USPSTF statement in the context of the national and international literature, including the concepts of major depressive disorder and suicidal behaviours, risk factors, early screening tools, pros and cons of early screening, treatment and interventions, and the value of the USPSTF statement in guiding primary care providers. Intending to serve as a reference for clinical healthcare professionals involved in the screening of children and adolescents for depression and suicide risk. Table and Figures | Reference | Related Articles | Metrics